Finn Brooks: Okay Juniper, quick question before we even start — have you ever voluntarily asked your boss for permission to do something you were already allowed to do?
Juniper Vale: I mean — no? That would be a very strange thing to do. Why?
Finn Brooks: Because Apple did it. The Financial Times reported — this is around July 8th, 2026 — that Apple is testing DRAM chips from ChangXin Memory Technologies, a Chinese state-backed manufacturer, for devices it sells in China. And then Apple went to U.S. officials and asked for commercial permission to use those chips more broadly. Even though there is currently no law requiring that ask.
Juniper Vale: So they can already do this legally.
Finn Brooks: They can. And the reason it gets even weirder — the Commerce Department proposed adding CXMT to the Entity List over alleged military ties, then hit pause on that during U.S.-China trade negotiations. So it's this open window that could close anytime, and Apple is in there asking for a handshake from the Trump administration anyway.
Juniper Vale: You know, the permission-seeking without a legal requirement — that tells you something about how politically exposed Apple thinks this is. Because CXMT isn't some fringe name. They're the fourth-largest DRAM manufacturer in the world.
Finn Brooks: Fourth largest. State-backed. And Apple is knocking on their door — so what we're trying to work out is whether Apple actually needs ChangXin, or whether this whole move is theater to squeeze their existing suppliers.
Juniper Vale: And honestly I'm not sure those two things are mutually exclusive. That's the interesting part.
Finn Brooks: But here's what actually makes it not theater — like, that's the part I keep getting stuck on. CXMT is already the fourth-largest DRAM wafer manufacturer on the planet. Eleven percent of global capacity, right now, in 2025. That's not a bluff you wave at Samsung. That's a real factory.
Juniper Vale: Think of it like this — you've been ordering from the same two or three food suppliers for years, and suddenly they both land a massive restaurant chain contract and your orders keep getting bumped. A new supplier opens down the street, has capacity, wants your business. That's the actual situation Apple is in. The AI boom basically vacuumed up all the high-bandwidth memory, and SK Hynix and Samsung are prioritizing those AI customers over Apple's commodity DRAM needs. Apple's order keeps getting pushed back.
Finn Brooks: And CXMT is the new supplier down the street.
Juniper Vale: With a very large kitchen. Their Hefei Phase II fab came online in early 2025 — 120,000 wafers a month right now, targeting 250,000 by 2026. That's not a pilot program.
Finn Brooks: Okay wait — and the yields are above 92%? On LPDDR5X, the actual chip type Apple is testing? Because I — that number is the one that kind of broke my brain a little when I saw it.
Juniper Vale: Above 92%, yeah. And pricing 15 to 20 percent below Micron, Samsung, and SK Hynix. Those two numbers together — that's the thing. It's not a race to the bottom on quality. The cost structure is just genuinely better.
Finn Brooks: Okay that is actually — no, wait, 15 to 20 percent cheaper with comparable yields? That's not a discount bin situation. That means CXMT has won on manufacturing, not just on price.
Juniper Vale: Which is why I'd push back a little on framing the whole thing as negotiating theater. Apple might genuinely need this. The shortage is real, the pricing pressure is real, and CXMT is running a 1α-nanometer class process at data rates around 6,400 megabits per second — I mean, that's not a chip you dismiss.
Finn Brooks: So the headline says geopolitical chess, but the actual story is — China figured out how to make the chip Apple needs, cheaper, at scale, and Apple would be kind of irrational to ignore it.
Juniper Vale: Okay but that's — wait, that's actually the part where I want to pump the brakes, because the take that's been circulating is that this is Apple diversifying its supply chain. And I don't think that's right.
Finn Brooks: No! That is the wrong read. Like, Apple made zero purchasing commitment. Testing is not sourcing. There's no contract, no volume order — just chips going into a lab somewhere.
Juniper Vale: And they asked for U.S. approval they don't legally need. That's — I mean, who does that? You do that when you want the paper trail, not the chips.
Finn Brooks: Right — and here's the tell. Micron's analysts are already saying Micron has nothing to worry about. Why? Because CXMT only makes commodity DRAM. They're not touching high-bandwidth memory, which is the stuff that actually defines where the market is going. So the leverage is real but also kind of... bounded?
Juniper Vale: But if Samsung and SK Hynix see Apple cozying up to CXMT — even in a lab — that's enough. You don't have to pull the trigger to move the price.
Finn Brooks: Okay but here's the part that actually — no, wait, this is the irony that kind of wrecked me. Apple's aggressive price squeezes during the last memory downturn? Those negotiations discouraged supplier investment. Which is directly cited as a reason the current shortage exists. Apple essentially bullied its suppliers into underinvesting, and now it's panicking about undersupply.
Juniper Vale: They created the hole they're now trying to climb out of.
Finn Brooks: And Congress already flagged this pattern — in 2022 they specifically warned Apple against sourcing from another blacklisted Chinese chipmaker. So Apple's not operating in a vacuum here, they know the political ceiling.
Juniper Vale: Which makes the permission-seeking make even more sense as a move. And honestly — what happens if that Entity List pause ends? That's the thread we need to pull on next, because the legal window Apple is standing in right now could close fast.
Finn Brooks: And it could close like — retroactively. The Commerce Department paused the Entity List move mid-trade negotiations, which means the moment those talks go sideways, the window doesn't just close, it closes on chips Apple might already have ordered.
Juniper Vale: That's the live wire. Picture a procurement manager at Apple, July 2026, opens a Slack from her team — CXMT passed early testing, Samsung is pushing price increases because HBM demand is eating their capacity, and the Entity List pause could end any week. She has to decide what to put in a memo to her VP. That memo exists right now, somewhere.
Finn Brooks: And whatever she writes is — it becomes evidence. Like, congressional evidence.
Juniper Vale: Which is exactly why Apple asked for permission it doesn't need. If the Trump administration signs off, that's not Apple's political risk anymore — it's shared. Apple is trying to distribute the liability before anything even ships.
Finn Brooks: Okay but — wait, does that actually work? Because if Congress came for Apple in 2022 over a different blacklisted supplier, approval from the executive branch doesn't exactly make the House Armed Services Committee go quiet.
Juniper Vale: No, you're right, it doesn't insulate them completely. But here's what changes the picture — China is already squeezing Apple from the other side. Forty-eight Chinese iOS developers filed an antitrust complaint with SAMR, China's market regulator, over App Store commissions. Apple cut the rate from 30 to 25 percent in March 2026 and the developers are still saying it's too high. So Apple is getting pressure from Beijing on one front and from Washington on another.
Finn Brooks: Wait — 48 developers filed formally? That's not a tweet campaign, that's a coordinated regulatory action.
Juniper Vale: Coordinated. And the CXMT move reads differently once you see it next to that. Apple isn't just buying chips — it's maybe buying goodwill with Beijing while it fights the App Store complaint. And then there's the IPO. CXMT is preparing a domestic IPO valued at up to three trillion yuan. That's roughly $400 billion. China is not treating CXMT like a supplier — they're treating it like a national asset they're about to list on an exchange.
Finn Brooks: Three trillion yuan — okay that changes what CXMT even is in this story. That's not a factory Apple can quietly walk away from if the politics get hot. That thing is going to be publicly traded, nationally visible, and the moment Apple's name is attached to those chips in any real volume, it's in the prospectus.
Juniper Vale: And that's — I mean, that's the part I can't resolve. If Apple gets U.S. approval and then just... doesn't order, what was the approval for? Does it go in a drawer and get faxed to Samsung's procurement team?
Finn Brooks: That is genuinely the question. Like — watch whether volume purchase orders follow. That's the only signal that matters. Everything before that is just paper.
Juniper Vale: We don't know. And I think that's actually the honest place to land — not unresolved in a frustrating way, just... actually open.
Finn Brooks: Yeah. That memo exists and we're not in it.
